Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Pacific Biosciences of California, Inc. (PACB) had Return on Equity of -10214.37% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$160.00M |
|
$-546.38M |
|
$114.22M |
|
$45.78M |
|
$713.87M |
|
$-553.86M |
|
$7.80M |
|
$-546.06M |
|
$-546.06M |
|
$-546.38M |
|
$-546.38M |
|
$-546.38M |
|
$-546.38M |
|
$-553.86M |
|
$-156.81M |
|
299.96M |
|
299.96M |
|
$-1.82 |
|
$-1.82 |
|
| Balance Sheet Financials | |
$375.05M |
|
$24.15M |
|
$409.03M |
|
$784.08M |
|
$72.83M |
|
$645.38M |
|
$705.90M |
|
$778.73M |
|
$5.35M |
|
$-327.54M |
|
$5.35M |
|
301.96M |
|
| Cash Flow Statement Financials | |
$-111.21M |
|
$115.45M |
|
$3.43M |
|
$57.59M |
|
$65.26M |
|
$7.67M |
|
$41.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.15 |
|
-- |
|
-- |
|
0.99 |
|
120.65 |
|
28.61% |
|
-346.15% |
|
-346.15% |
|
-98.01% |
|
-341.28% |
|
-341.47% |
|
$-113.92M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
2.32 |
|
4.51 |
|
80.86 |
|
|
Return on Equity |
-10214.37% |
166.81% |
|
-69.68% |
|
-83.96% |
|
$0.02 |
|
$-0.38 |
|
$-0.37 |
|